Marina Konopleva, MD, PhD

No bio available.

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Redona
    Topic: 
    Consulting
    Date added: 
    04/22/2024
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Sanofi Aventis
    Topic: 
    Consulting
    Date added: 
    04/22/2024
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Sanofi Aventis
    Topic: 
    Research/clinical trials
    Date added: 
    04/22/2024
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Sellas
    Topic: 
    Consulting
    Date added: 
    04/22/2024
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Stemline Therapeutics
    Topic: 
    Consulting
    Date added: 
    04/22/2024
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Stemline Therapeutics
    Topic: 
    Research/clinical trials
    Date added: 
    04/22/2024
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Stemline Therapeutics
    Topic: 
    Advisory Board
    Date added: 
    04/22/2024
  • Attribution: 
    Self
    Type of financial relationship: 
    Independent contractor
    Ineligible company: 
    Vincerx
    Topic: 
    Consulting
    Date added: 
    04/22/2024
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Vincerx
    Topic: 
    Advisory Board
    Date added: 
    04/22/2024

Pages

Return to 2024 Summit on Hematological Cancers